Therapeutic Antibodies

  • Image of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Disease Building
  • Image of a person using a pipet

    The CPRIT Therapeutic Antibody Core

    We offer Texas-wide access to specialized technical expertise, instrumentation, and automation to advance lead antibodies with “drug like” properties from academic laboratories to the stage of preclinical development.

  • Image of a microscope stage

    Therapeutic Antibody Development

    Lead Identification – Lead Optimization – Lead Construction – Antibody Production

Zhiqiang An, PhD, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth Houston. (Photo by UTHealth Houston)

New antibody shows therapeutic effects in mice with Alzheimer’s disease (UTHealth Houston News)

September 7, 2022 | Caitie Barkley

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.

New antibody drug shows promise in mouse study; vaping may increase lung vulnerability to virus

New antibody drug shows promise in mouse study; vaping may increase lung vulnerability to virus

March 25, 2022 | Nancy Lapid

The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS.